Recent events
Recent events tied to this brand in public sources.
Back to profile49 entries · Page 2 of 3
2021
十月稻田 completes RMB 1.45 billion Series B funding
十月稻田农业科技有限公司 announced that it completed a Series B funding round of RMB 1.45 billion on May 31, led jointly by Sequoia Capital China and Yunfeng Fund.
2021
Mech-Mind completes Series C funding
Mech-Mind Robotics completed Series C funding led by Meituan, with participation from existing investors including Sequoia Capital China and Source Code Capital. The investment brought Mech-Mind's total funding to over USD 100 million.
2021
Pudu completes Series C funding
Pudu Robotics announced that it had completed a CNY 500 million Series C financing round, with new strategic shareholders and continued investments from existing shareholders Meituan and Sequoia Capital China Fund.
2021
Dejin Medical completes Series B financing
Hangzhou Dejin Medical Technology, part of Denovo Medical Group, announced that it had recently completed a Series B financing worth several hundred million US dollars. The proceeds were stated to be mainly for technology innovation and product development in mitral and tricuspid valve disease treatment.
2021
Weimu Bio completes RMB 300 million Series D financing
Weimu Bio announced that it had completed RMB 300 million in Series D financing. The funds will support clinical development of several ophthalmic drug candidates, including its ongoing U.S. Phase II study of VVN001 for dry eye disease.
2021
Yongliu Technology completes Series A funding
Yongliu Technology announced that it had completed a Series A financing of tens of millions of yuan, led solely by Sequoia China, with Hangzhou Wanlun Shangde participating and existing angel investor Yidu Capital adding further investment.
2021
Guanyuan Data completes B+ funding round
Guanyuan Data announced on March 29, 2021, that it had completed a RMB 100 million B+ funding round. Unicorn Capital Partners led the round, and existing shareholders including Sequoia China, Xiang He Capital and Linear Capital participated.
2021
Jianai completes RMB 800 million Series B funding
Jianai disclosed that it had completed RMB 800 million in Series B funding recently. Existing investors increased their investment, and new investors included Sequoia China, Yunfeng Fund, Puru Investment Fund, and Dehong Capital.
2021
Tezign completes C2 funding round
Tezign announced that it had completed its C2 funding round, led by Temasek, with existing shareholders also participating.
2021
ABclonal Biotechnology completes Series C financing
ABclonal Biotechnology completed a $92.9 million Series C financing led by Sequoia Capital China and LYFE Capital. The release says the funding will support research and development of in vitro diagnostic raw materials and expansion of research-reagent production capabilities.
2021
Yuanxin Technology completes RMB 3 billion Series E financing
Yuanxin Technology announced that it completed a RMB 3 billion Series E financing round, jointly led by Sequoia Capital China Fund and Tencent, with other investors participating.
2021
INTAMSYS completes third-round financing
INTAMSYS announced that it had completed a third financing round worth tens of millions of yuan, led by Sequoia Capital China Fund, with Brizan participating and Gao Bingqiang making a further investment.
2021
China Pacific Insurance and Sequoia China announced a health-industry strategic partnership
China Pacific Insurance and Sequoia China held a health-industry strategic cooperation and fund-launch ceremony in the Lingang New Area of the Shanghai Free Trade Zone, with a focus on investment opportunities across the health industry.
2020
Dymind completes $100 million Series C financing
Dymind announced that it had completed a $100 million Series C financing led by Fidelity Management & Research Company, LLC, with Sequoia Capital China, Kaiser Permanente, and E Fund participating.
2020
Blue Arrow Aerospace completes RMB 1.2 billion funding round
Blue Arrow Aerospace completed a RMB 1.2 billion C+ funding round in September 2020. The company said the funds would support development of its Zhuque-2 liquid launch vehicle series.
2020
Blue Arrow completes RMB 1.2 billion Series C+ funding round
Blue Arrow announced that it completed a RMB 1.2 billion Series C+ funding round in September, led jointly by Sequoia Capital China Fund, Country Garden Venture Capital, and listed companies under Matrix Partners China and Cornerstone Capital.
2020
Huohua Thinking completes a US$150 million E1 funding round
Huohua Thinking announced that it had completed a US$150 million E1 funding round led by KKR, with existing investors also participating.
2020
Xpeng raises $500 million in funding
Xpeng Motors raised $500 million from private investors, including Aspex, Coatue, Hillhouse Capital and Sequoia Capital China.
2020
Zuoyebang completes $750 million Series E funding round
Online education platform Zuoyebang announced that it had completed a $750 million Series E funding round. The round was led by FountainVest Partners and Tiger Global, with existing and new investors including Qatar Investment Authority, Sequoia Capital China, SoftBank Vision Fund I, Tiantu Capital and Xiang He Capital participating.
2020
Yuanxin Technology completes 600 million yuan D1 funding round
Yuanxin Technology announced that it had completed a D1 funding round of 600 million yuan, with investment from Sequoia China, Qiming Venture Partners, Yingke Capital, CITIC Securities and Index Capital.